
Publix recalls baby food pouches over potential lead contamination
Publix, a national supermarket chain, is voluntarily recalling baby food that could be contaminated with lead, the company announced this week.
The company said it discovered the problem through routine testing and has pulled its GreenWise Pear, Kiwi, Spinach & Pea Baby Food pouches from its shelves, according to a news release, which said there were 'no reported cases of illness' related to the product.
It's the second recall of baby food for potential lead contamination in recent weeks — and in both cases, the Food and Drug Administration didn't issue its own news release to warn the public, which safety experts and advocates said surprised them.
The FDA did not explain why it hadn't issued a news release for the Publix recall or Target's voluntary recall in March of its Good & Gather Baby Pea, Zucchini, Kale & Thyme Vegetable baby food puree. In that case, the FDA posted details about the recall in the agency's public recall-monitoring database.
'The FDA is committed to ensuring that all necessary information regarding product recalls is promptly communicated to protect public health,' the agency said in a statement.
Publix did not respond to a request for comment. Target said that its Good & Gather recall 'involved a limited amount of product, which we took immediate action to remove from our shelves.'
The recalls come amid heightened concern about contaminated baby food, following the 2023 recall of apple cinnamon puree pouches for children that had elevated levels of lead. And they're also occurring as the Trump administration pledges to make baby food safer through increased testing, though some safety advocates say those promises are undermined by the deep staffing and funding cuts to federal health agencies.
here.
The FDA does not issue news releases for all food recalls, but it generally does so in cases where it determines there is a serious risk to public health, food safety experts and advocates said. Last year, the FDA issued news releases for multiple recalls of lead-contaminated cinnamon.
Sarah Sorscher, director of regulatory affairs at the Center for Science in the Public Interest, an advocacy group, said it was 'concerning' that the FDA had chosen not to publicize the two recent recalls, given the serious health risk that lead poses to babies and young children, including brain damage, slower development and behavioral problems.
'There is no safe level of lead,' Sorscher noted. The FDA amplifying a recall can help reach more consumers, she added, especially for products like baby food that can have a long shelf life. 'It increases the attention that stores and consumers give it, so that it's more likely to be pulled off the shelf,' she said.
Lead contamination can happen during the manufacturing process, but it can also occur through contaminated soil used to grow produce.
In January, in the final weeks of the Biden administration, the FDA created a maximum level for lead in baby food for the first time. Though the standard is voluntary, it has helped push baby food companies to conduct more testing and initiate recalls, food safety experts and advocates said.
'Industry is taking that guidance to heart and being more proactive,' said Jennifer van de Ligt, a baby food expert who was among the FDA scientists laid off in recent weeks. 'If that guidance stays in place, it should put pressure on industry to comply.'
The Trump administration has launched a high-profile effort to make infant formula and baby food safer under Operation Stork Speed. The administration said in March that the program would include 'increasing testing for heavy metals and other contaminants in infant formula and other foods children consume.'
The FDA has not provided details about this increased testing and, when asked this week, instead pointed to its new effort to review nutrients in baby formula. Meanwhile, food safety advocates and former agency staff members have raised concerns about the impact of the Trump administration's mass layoffs on food safety issues like lead contamination.
In April, the agency shuttered a federal laboratory that specialized in testing food for lead and other heavy metals and terminated its staff members, only to backtrack weeks later. The FDA also stalled in publicizing food safety warnings after terminating communications and public records staff, sources said.
The administration additionally fired federal experts for the Centers for Disease Control and Prevention who worked to prevent lead poisoning in children and proposed eliminating the lead poisoning prevention program in a leaked budget draft. In a statement, a CDC spokesperson said the agency reorganization plans were being finalized but that 'the work of this program will continue.'
Sorscher argued that there was a contradiction between the administration's stated support for baby food safety and many of its actions. 'There is what they're saying they want to do to clean up the food supply, and what they're actually doing,' she said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


NBC News
an hour ago
- NBC News
Democratic governors seek to roll back state-funded health care for undocumented immigrants
A trio of states with Democratic governors viewed as potential 2028 presidential candidates have taken steps in recent weeks to freeze or cut government-funded health care coverage for undocumented immigrants. Democratic Govs. Gavin Newsom of California, JB Pritzker of Illinois and Tim Walz of Minnesota have largely attributed the proposals to budget shortfalls stemming from original plans to expand health care to immigrants without legal status. But the moves also occur against the backdrop of broader debate within the Democratic Party over how to handle immigration, an issue that dragged it down in the last election and that President Donald Trump and the GOP have continued to try to capitalize on. The plans, which would scale back health care coverage for undocumented immigrants in the three Democratic-led states just years after it was expanded, have angered progressives and immigrant advocacy groups, who warn the party risks alienating its base — particularly as protests against Trump's deportation plans break out around the country. The latest development came in Minnesota on Tuesday, after both chambers of the Legislature passed a bill to end state-funded health care for undocumented adults. The bipartisan effort advanced through the Republican-controlled House and the Democratic-controlled Senate as part of attempts to balance the state budget. It now goes to Walz, who has said he'll sign it. The bill would end undocumented adults' eligibility for MinnesotaCare — the state-funded health insurance program for low-income residents — effectively reversing one of the signature policy wins Walz secured during a landmark legislative session in 2023, when Democrats were in full control of state government. Undocumented children would remain eligible to enroll in the program under the legislation. In California, Newsom unveiled a budget plan last month that would cut back on health care benefits for undocumented immigrants — a stark reversal from his promises of universal health care for all the state's residents, regardless of their immigration status. Newsom's plan in his 2025-26 budget has called for freezing enrollment for undocumented adults to receive the full scope of the state's Medicaid program, known as Medi-Cal. Newsom's office has said the changes would apply only to new applicants over age 19, that existing enrollees wouldn't be kicked off their plans and that the freeze, which would begin next year, wouldn't apply to people enrolled in limited plans. Newsom's proposed changes also included a new $100 monthly premium for adults 19 and older with 'unsatisfactory immigration status' beginning in 2027. His expansion of Medi-Cal has cost far more than his administration anticipated. Newsom has said the changes will help to balance the state's budget, which has run a multibillion-dollar shortfall that he has blamed on Trump's tariffs, as well as growing costs from higher enrollment in Medi-Cal. Meanwhile, Illinois remains on track by the end of the month to end a program — called Health Benefits for Immigrant Adults — that provides state-funded health care coverage for more than 30,000 low-income adults who are living in the state without documentation. Similarly, the program in Illinois was more expensive than expected when it was created in 2021. Pritzker's latest budget, which the Democratic-led Legislature passed last month, proposed eliminating it by July 1. While the moves would help those states recalibrate their budgets, a sweeping Trump-backed domestic policy bill moving through Congress proposes slashing Medicaid funding for states that provide health care coverage to undocumented immigrants. Trump also signed an executive order this year targeting undocumented immigrants' access to government assistance programs. In response to questions from NBC News, Newsom spokesperson Elana Ross reiterated his statement in his initial announcement of the changes last month that 'instead of rolling back the program — meaning cutting people off for basic care — we're capping it.' Pritzker's office said in an email that 'this year, passing a balanced budget required the difficult decision that reflects the reality of Trump and Republicans tanking our national economy and attempting to strip away healthcare.' A Walz spokesperson didn't respond to questions about Minnesota's plan, which was the result of a compromise after Republican lawmakers had pushed to end the entire MinnesotaCare program. 'No one got everything they wanted,' Walz said last month after he reached a tentative deal with Republicans on the budget, which was finalized in a special session this week. 'There were very difficult conversations about issues that were very dear to each of these caucuses. But at the end of the day, we were able to come to this agreement.' Blowback from the left Immigrant advocacy groups have panned the moves, saying they risk further imperiling the broader health care system, and blasted Democrats for succumbing to Trump's attacks. 'We urge state leaders to build on their progress, rather than placing the health of their residents at risk,' said Tanya Broder, the senior counsel for health and economic justice policy at the National Immigration Law Center. 'Particularly as extremist politicians scapegoat and target immigrants, we are counting on state officials to do the right thing and hold the line. 'As states increasingly have recognized, a community's health and well-being depend on ensuring that everyone has access to health care. Immigrants pay billions of dollars in federal, state and local taxes, yet many are excluded from critical health care programs,' she added. 'Terminating state coverage for immigrants will compromise our collective health, as well as the health care infrastructure that serves all of us.' Some progressives questioned whether the moves were part of a broader strategy by the three governors to move to the right on the broader issue of immigration, which polling has shown still remains one of Trump's strongest issues. They said they could face a backlash from their base by departing from positions on supporting immigrant communities and expanding health care. 'It really feeds into the conservative narrative that undocumented immigrants are a drain on our communities,' said Jennifer Driver, a senior director at the State Innovation Exchange, a progressive legislative policy group. 'This assumption that by moving more to the middle or to the right that you're going to recruit some people back — I think it's a miscalculation. 'The frustration that you're seeing in the Democratic base is due to this kind of this waffling, this kind of idea that 'OK, yes, we are progressive — but only in some moments,'' Driver added. Other strategists suggested it remained too early to gauge whether a broader shift was in play as governors and other lawmakers positioned themselves for potential 2028 White House bids, and they emphasized that the threats blue states face from Trump are serious. 'The Trump administration is squeezing the hell out of states,' said Jeff Blodgett, a Minnesota-based Democratic strategist who was a campaign manager for the late Sen. Paul Wellstone and the state director for both of Barack Obama's presidential campaigns. 'There's just a lot of concern about current and future budgets given what the federal government is doing to states.'


Daily Mail
13 hours ago
- Daily Mail
EXCLUSIVE Biden White House doctor accused of disgusting act on the job... as he braces for Congress grilling over health cover-up
Vicious accusations are flying among three former White House doctors, as President Joe Biden 's personal physician is set to be hauled in front of . On Tuesday, ex-Trump White House doctor turned Republican congressman Ronny Jackson told the Daily Mail that former Biden doctor, Dr Kevin O'Connor, engaged in shockingly bizarre and sexually inappropriate behavior in the White House.


Medical News Today
15 hours ago
- Medical News Today
How Tremfya works: Mechanism of action explained
How it works How long it takes to work Tremfya (guselkumab) is a prescription drug that treats psoriatic arthritis, plaque psoriasis, and ulcerative colitis. Its mechanism of action is binding to interleukin-23 that's overactive. Tremfya belongs to a class of medications called interleukin-23 blockers. It's a type of biologic called a monoclonal antibody, which is a protein that attaches to substances in the body. Tremfya works by binding to interleukin-23 (a protein in the body) that's overactive. By binding to this protein, Tremfya decreases how active your immune system is to ease inflammation and decrease symptoms of your condition. The way a drug works is known medically as its mechanism of action. The mechanism of action for Tremfya may vary depending on the condition it's being used to treat. Tremfya is approved by the Food and Drug Administration (FDA) to treat certain conditions, including psoriatic arthritis. When you have psoriatic arthritis, your immune system (your body's defense against infections) is overactive. It attacks healthy tissues and cells, causing joint pain and inflammation. It also causes your body to make too many skin cells, leading to a buildup of cells and areas called plaques. These plaques are flushed, itchy patches on your skin. Tremfya is FDA-approved to treat moderate to severe plaque psoriasis. This condition is one of many types of psoriasis. When you have plaque psoriasis, your immune system is overactive. It causes your body to make too many skin cells, leading to a buildup of cells and areas called plaques. These plaques are itchy patches on your skin. They may look pink or be darker than your skin color. Sometimes, they may look white and scaly. Tremfya may be an option for plaque psoriasis treatment if you can receive either: systemic therapy (treatment that affects your whole body), or phototherapy (treatment with light) Tremfya is FDA approved to treat moderate to severely active ulcerative colitis (UC) in adults. When UC is active, it's causing symptoms. Tremfya is prescribed to help put UC in remission and keep it there. With remission, you have few or no symptoms of the condition. Ulcerative colitis is a type of inflammatory bowel disease (IBD) that affects the colon and rectum. It's thought to result from overactivity in a person's immune system. With UC, you have inflammation in your colon, rectum, or both. In severe cases, ulcers can also form in these areas. Symptoms of this condition include blood in your stool, diarrhea, abdominal pain or cramps, and weight loss. For this condition, Tremfya is typically prescribed alone. Your doctor may also prescribe nonbiologics to treat an ulcerative colitis flare-up. Tremfya is FDA approved to treat Crohn's disease. Like UC, Crohn's disease is a type of IBD. Unlike UC, which affects the colon and rectum, Crohn's disease can affect your entire digestive system, including your stomach, intestines, and colon. To find out more about Crohn's disease, visit our IBD hub. In clinical trials, people with plaque psoriasis often experienced a reduction in symptoms after receiving three doses of Tremfya over 16 weeks. Also, more than half of the people receiving Tremfya for psoriatic arthritis in clinical trials experienced a decrease in symptoms after 16 weeks of treatment. In a clinical trial of Tremfya for UC, more than half of the people receiving the drug experienced a decrease in symptoms after 12 weeks. Some people also experienced remission (few or no symptoms of UC). If you have more questions about how long it takes for Tremfya to work, talk with your doctor or pharmacist. Disclaimer: Medical News Today has made every effort to make certain that all information is factually correct, comprehensive, and up to date. However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional. You should always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. The absence of warnings or other information for a given drug does not indicate that the drug or drug combination is safe, effective, or appropriate for all patients or all specific uses. Medical News Today has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical journals and associations. We only use quality, credible sources to ensure content accuracy and integrity. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.